Swiss Commercial Services Stock News

SWX:HIAG
SWX:HIAGReal Estate

Assessing HIAG Immobilien Holding (SWX:HIAG) Valuation After Strong 2025 Profit Guidance And Recent Share Price Momentum

HIAG Immobilien Holding (SWX:HIAG) has drawn attention after issuing new guidance indicating that its 2025 consolidated net profit is expected to be 50% to 55% higher than the 2024 figure of CHF 75.2 million. See our latest analysis for HIAG Immobilien Holding. The updated profit outlook arrives after a solid run in HIAG Immobilien Holding's share price, with a 30 day share price return of 4.89%, a 90 day share price return of 13.09% and a 1 year total shareholder return of 45.44%, which...
SWX:COTN
SWX:COTNElectronic

Assessing Comet Holding (SWX:COTN) Valuation After AI Driven Semiconductor Earnings Momentum

Comet Holding (SWX:COTN) is back in focus after reporting revenue of CHF 483.201 million and net income of CHF 38.922 million, as investors react to AI driven semiconductor manufacturing demand. See our latest analysis for Comet Holding. At a share price of CHF299.40, Comet Holding has logged a 33.07% 1 month share price return and a 58.41% 3 month share price return. The 1 year total shareholder return of 13.17% points to momentum that has strengthened more recently as investors react to AI...
SWX:ADEN
SWX:ADENProfessional Services

Does LHH’s New HR Consulting Push Change The Bull Case For Adecco Group (SWX:ADEN)?

Adecco Group’s LHH brand recently launched a global HR and talent consulting business, aiming to expand its higher-value advisory and support offerings. This move signals a push toward more consultative, margin-rich services that could reshape how Adecco balances traditional staffing with broader workforce solutions. Next, we’ll examine how this LHH consulting launch influences Adecco’s investment narrative, particularly its push into higher-margin HR services. Trump's oil boom is here -...
SWX:LONN
SWX:LONNLife Sciences

A Look At Lonza Group’s (SWX:LONN) Valuation After Earnings Growth Guidance And Dividend Hike

Why Lonza’s latest earnings matter for shareholders Lonza Group (SWX:LONN) just released full year 2025 results, issued 2026 sales growth guidance, and outlined a proposed 25% dividend increase, giving investors fresh information on profitability, cash returns, and future revenue expectations. See our latest analysis for Lonza Group. Despite the strong 2025 results and brighter 2026 sales guidance, Lonza Group’s recent momentum has been soft, with a 1 year total shareholder return decline of...
SWX:UHR
SWX:UHRLuxury

Swatch Group (SWX:UHR) Valuation After Rebound In Sentiment And 2026 Growth Outlook

Why Swatch Group Stock Is Back on Investors’ Radar Swatch Group (SWX:UHR) moved into focus after management reported stronger sales momentum in late 2025, projected substantial growth for 2026, and kept its dividend unchanged despite a sharp profit decline. See our latest analysis for Swatch Group. The latest earnings update and dividend decision have shifted attention back to the share price, which has reacted sharply in the short term. Swatch Group’s 1 day share price return of 13.42% and 7...
SWX:LAND
SWX:LANDElectronic

A Look At Landis+Gyr Group’s Valuation As Mitsubishi Electric Partnership Advances Grid Edge Plans

Mitsubishi Electric Corporation and Landis+Gyr Group (SWX:LAND) have signed a Memorandum of Understanding to work together on grid edge intelligence and energy transition solutions, initially targeting North American utilities. See our latest analysis for Landis+Gyr Group. The Mitsubishi Electric agreement lands after a recent Q3 sales or trading statement call and comes as the share price sits at CHF54.3, with a 7 day share price return of 6.68% but a 1 year total shareholder return of 8.23%...
SWX:BEAN
SWX:BEANBuilding

Did BELIMO’s 23.3% Sales Surge in 2025 Just Shift BELIMO Holding's (SWX:BEAN) Investment Narrative?

In January 2026, BELIMO Holding AG reported its 2025 results, revealing accelerated sales growth of 23.3% in local currencies and CHF 1,121 million in sales. This sharp step-up in growth relative to the prior year highlights how BELIMO’s offering is gaining traction across its key end markets. We’ll now examine how this acceleration in sales growth shapes BELIMO’s investment narrative and what it could mean for investors. The end of cancer? These 29 emerging AI stocks are developing tech...
SWX:ABBN
SWX:ABBNElectrical

ABB (SWX:ABBN) Is Up 10.4% After New Buyback And Record Q4 2025 - Has The Bull Case Changed?

ABB Ltd has completed its 2025 share buyback, reported record fourth-quarter 2025 results with higher revenue and earnings, and announced a new US$2.00 billion share repurchase program running through January 27, 2027 for capital reduction and employee share plans. The company coupled the buyback with guidance for comparable revenue growth of 7%–10% for the first quarter and 6%–9% for full-year 2026, highlighting confidence backed by a record order backlog and expanding electrification and...
SWX:ROG
SWX:ROGPharmaceuticals

Roche Holding (SWX:ROG) Net Margin Jump To 20.3% Tests Long Term EPS Bear Case

How Roche Holding (SWX:ROG) Just Framed Its FY 2025 Story Roche Holding (SWX:ROG) opened FY 2025 with first half revenue of CHF31.8b and basic EPS of CHF9.31, setting the tone with headline numbers that put both the top line and per share earnings clearly on the radar for investors following this latest update. Over the recent reporting periods, revenue has moved from CHF30.8b in the first half of 2024 to CHF31.6b in the second half and then to CHF31.8b in the first half of 2025. Basic EPS...
SWX:BARN
SWX:BARNFood

Cocoa Volume Slump And Value Focus Might Change The Case For Investing In Barry Callebaut (SWX:BARN)

In late January 2026, Barry Callebaut reported a 22% decline in cocoa division sales volume for the quarter ended November 30, citing weak global demand and a tilt toward higher-return product segments against a backdrop of abundant cocoa supplies and pressured prices. This combination of softer end-consumer appetite for chocolate and a deliberate focus on more profitable cocoa uses signals an important shift in how Barry Callebaut is balancing volume and value across its business. We will...
SWX:UBSG
SWX:UBSGCapital Markets

What UBS Group (SWX:UBSG)'s Push Into Crypto Trading and Premium Advisory Means For Shareholders

UBS has promoted long-time banker Nicholas Hinnen to the newly created role of head of premium advisory specialists APAC Switzerland and is also preparing to let select clients trade bitcoin and Ether, expanding its digital asset offering across regions. Together, the leadership move in ultra-wealth advisory and the planned crypto trading program highlight UBS’s push to refine high-end client services while responding to evolving digital asset demand. Next, we’ll consider how UBS’s move into...
SWX:UBXN
SWX:UBXNSemiconductor

A Look At u‑blox Holding (SWX:UBXN) Valuation As AI Demand And Earnings Outlook Draw Attention

AI driven demand puts u-blox Holding (SWX:UBXN) in focus ahead of earnings Market attention has turned to u-blox Holding (SWX:UBXN) as investors weigh its role in AI related GNSS and wireless modules, and look ahead to earnings, with revenue mix and margin recovery under scrutiny. See our latest analysis for u-blox Holding. After a strong run, with an 81.21% year to date share price return and a 108.01% total shareholder return over the past year, recent gains around AI related GNSS demand...
SWX:NESN
SWX:NESNFood

Assessing Nestlé (SWX:NESN) Valuation After Baby Formula Toxin Recalls And Intensifying Regulatory Scrutiny

Regulators have confirmed a food poisoning toxin in some Nestlé (SWX:NESN) baby formula products, prompting recalls and investigations that are now central to how investors assess the company’s risk profile and potential reputational overhang. See our latest analysis for Nestlé. The recent baby formula recalls and food safety investigations come after a period where Nestlé’s 30 day share price return of 6.74% decline and 90 day share price return of 4.49% decline have weighed on sentiment,...
SWX:ROG
SWX:ROGPharmaceuticals

Roche Holding (SWX:ROG) Valuation After CT-388 Obesity Data Earnings Strength And Dividend Proposal

Roche Holding (SWX:ROG) is in focus after reporting full year 2025 earnings alongside standout Phase II data for its obesity candidate CT-388 and proposing a higher dividend, a combination that sharpens attention on its cardiometabolic ambitions. See our latest analysis for Roche Holding. The latest CT-388 data and dividend proposal come after a strong run in the share price, with a 90 day share price return of 35.46% and a 1 year total shareholder return of 26.68%. This suggests momentum has...
SWX:AMRZ
SWX:AMRZBasic Materials

Is Amrize’s (SWX:AMRZ) Q4 Earnings Call Set To Reframe Its Long-Term Growth Narrative?

Amrize has announced it will release its fourth-quarter 2025 results after the U.S. market closes on February 17, 2026, followed by a webcast the next morning to discuss the numbers with investors. Fresh analyst coverage, including updated ratings and commentary, is sharpening market attention on how these upcoming results could shape perceptions of Amrize’s outlook. We’ll now examine how the upcoming fourth-quarter earnings release and related analyst commentary may influence Amrize’s...
SWX:ABBN
SWX:ABBNElectrical

ABB (SWX:ABBN) Net Margin Improvement Tests Justification For Premium P/E Valuation

How ABB (SWX:ABBN)'s FY 2025 Numbers Set the Stage ABB (SWX:ABBN) closed FY 2025 with fourth quarter revenue of US$9.1b and basic EPS of US$0.70, alongside trailing twelve month revenue of US$33.2b and EPS of US$2.50 that frame the full year picture. Over recent periods, the company has seen quarterly revenue range from US$7.9b to just over US$9.0b and EPS move from US$0.54 in Q4 2024 through to US$0.70 in Q4 2025, giving investors a clear read on how the top line and per share earnings have...
SWX:NOVN
SWX:NOVNPharmaceuticals

How Novartis’ AI Health Partnerships and NFL Campaign Will Impact Novartis (SWX:NOVN) Investors

At the 2026 World Economic Forum in Davos, Novartis Chairman Dr. Giovanni Caforio announced a past AI- and data-driven national cardiovascular disease prevention partnership with Brunei’s Ministry of Health and EVYD Technology, while Novartis also unveiled a prostate cancer awareness campaign with the NFL built around a “Relax, it’s a blood test” Super Bowl commercial. Together, these initiatives position Novartis as a healthcare innovator using large-scale data, artificial intelligence and...
SWX:UHR
SWX:UHRLuxury

Is Swatch Group (SWX:UHR) Pricing Look Stretched After Recent Share Price Rebound

If you are wondering whether Swatch Group shares still offer value after recent moves, this article walks through what the current price could be saying about the stock. The share price last closed at CHF 183.00, with returns of 10.2% over 7 days, 8.8% over 30 days, 6.4% year to date, 11.4% over 1 year, and longer term returns of 38.7% decline over 3 years and 23.1% decline over 5 years. Recent news around Swatch Group has largely focused on the broader watch and luxury goods sector,...